Ellenbarrie Industrial Gases Limited share price

Key numbers

Market cap

₹ 5,193 Cr

Current price

₹ 368.50

52-week high / low

₹ 502 / 175

Stock P/E

42.9

Book value

₹ 69.3

Dividend yield

0.00%

ROCE

15.2%

ROE

14.2%

Debt to equity

0.19

Sales growth (3 yrs)

16.9%

Profit growth (3 yrs)

54.8%

1-year return

-28.4%

About Ellenbarrie Industrial Gases Limited

Ellenbarrie Industrial Gases Limited manufactures industrial and medical gases in India. It offers industrial gases, such as oxygen, nitrogen, argon, carbon dioxide, helium, acetylene, hydrogen, nitrous oxide, synthetic air, and special gases; and medical gases, including medical oxygen, medical nitrogen, medical nitrous oxide, and medical grade carbon dioxide. The company also provides project engineering services comprising design, engineering, supply, installation and commissioning of tonnage ASUs, and related projects; medical gas pipeline services consisting of supply, installation, and commissioning of medical gas pipeline systems; and medical equipment, which include emergency and transport ventilators, central sterilization system, lung function testing system, and electro-cardiograph machine. In addition, it is involved in the construction of cryogenic and non-cryogenic air separation plants. Ellenbarrie Industrial Gases Limited was incorporated in 1973 and is headquartered in Kolkata, India.

Quarterly results

Consolidated figures in ₹ crores

Concall summary (2026-08-13)

AI summary of the earnings call transcript · tone: Positive · source document

Guidance & outlook

• Revenue from operations stood at 987 million compared to 836 million in Q1 of FY26 and 874 million in Q4 of FY26.
• EBITDA stood at 387 million compared to 318 million in Q1 of FY26 and 258 million in Q4 of FY26.

Growth & demand

• This represents a growth of 18% on a year-on-year basis and 13% sequentially.
• This represents a growth of 21% on a year-on-year basis and 50% sequentially.

Margins & costs

• The improvement in EBITDA was supported primarily by higher operating efficiency of our new plant, disciplined cost control, higher production, and some benefit from higher argon production and pricing.
• And, you know, I think when we talk of 40% margins, I think that's more on a sort of a longer- term margin, target margin that we have, rather than sort of being able to guarantee that every quarter we'll achieve that.

Capex & expansion

• And hence, we need a ramp up period for the capacity to get to that, you know, 80 to 90% capacity utilization, which we feel is the sweet spot.
• And as capacity expansion kind of unfolds, we would expect to see EBITDA margin numbers of 40% or higher.

Balance sheet & cash

• Employee costs and other operating expenses were also kept well under control during the quarter, supporting our broader focus on cost discipline, operating leverage, and margin protection.

Peers in Chemicals

• Navin Fluorine International Limited
• Deepak Nitrite Limited
• Deepak Fertilisers And Petrochemicals Corporation Limited
• Tata Chemicals Limited
• Gujarat Narmada Valley Fertilizers & Chemicals Limited
• Raghav Productivity Enhancers Limited
• Archean Chemical Industries Limited
• Foseco India Limited
• Gujarat Alkalies and Chemicals Limited
• Epigral Limited